semaglutide fda label Updates Ozempic amid Reports of Intestinal Blockages Novo Nordisk secures FDA approval

A Boston startup wants to turn GLP-1 weight loss therapy into a once-weekly patch

Ageless Foundation Laboratories, GLP-1 PRO, 60 Veg Capsules

A population-based cohort study of nearly 114,000 patients with T2D found that use of GLP-1s, compared with SGLT-2 inhibitors, was associated with a 27% higher relative risk of being diagnosed with GERD and a 55% higher relative risk of GERD-related complications

Despite their established glucose-lowering effects, there is no consensus among global experts and modern guidelines regarding the priority of SUs in relation to other therapeutic options, given the lack of evidence that SUs are associated with a low risk of macrovascular events and excess mortality

Looking for Tirzepatide or Semaglutide near you